Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression

Genes and Development

Volumn 14, Issue 17, 2000, Pages 2185-2191

  O'Hagan, Rónán C ^a,b   Ohh, Michael ^a   David, Gregory ^a,b   De Alboran, Ignacio Moreno ^b,d   Alt, Frederick W ^b,d   Kaelin Jr, William G ^a,c   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cell cycle; Cul1; Myc; p27(kip1); Ubiquitin dependent proteolysis

Indexed keywords

ONCOPROTEIN; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; EMBRYO; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; BLOTTING, NORTHERN; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CULLIN PROTEINS; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENDOPLASMIC RETICULUM; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PEPTIDE SYNTHASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RETROVIRIDAE; S PHASE; SKP CULLIN F-BOX PROTEIN LIGASES; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 0033856881     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.827200     Document Type: Article

References (44)

1. Kip1 meets SKP2: New links in cell-cycle control
2. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity
3. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts
4. Sequence-specific DNA binding by the c-Myc protein
5. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
6. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
7. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
8. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
9. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E
10. The MYC protein activates transcription of the alpha-prothymosin gene
11. The role of protein stability in the cell cycle and cancer
12. Cdc25 cell-cycle phosphatase as a target of c-myc
13. Participation of cyclin A in Myc-induced apoptosis
14. c-Myc enhances protein synthesis and cell size during B lymphocyte development
15. Drosophila myc regulates celluIar growth during development
16. Regulation of cell cycle duration by c-myc levels
17. A quantitative cytochemical investigation of the relationship between cell mass and initiation of DNA synthesis in mouse fibroblasts in vitro
18. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family
19. Proteolysis and the G1-S transition: The SCF connection
20. Suppression of Myc, but not Ela, transformation activity by Max-associated proteins, Mad and Mxil
21. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
22. c-Myc transrepression and cell transformation
23. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
24. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II
25. Increased proteasome-dependent degradation of the cyclindependent kinase inhibitor p27 in aggressive colorectal carcinomas
26. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination
27. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points
28. p27 expression and gastric carcinoma
29. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
30. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication
31. Mysterious liaisons: The relationship between c-Myc and the cell cycle
32. Gene-target recognition among members of the myc superfamily and implications for oncogenesis
33. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
34. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
35. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
36. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis
37. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
38. Essential role for Max in early embryonic growth and development
39. Cancer prognostics: Past, present and p27
40. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes
41. p45SKP2 promotes p27Kip 1 degradation and induces S phase in quiescent cells
42. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27
43. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc
44. Deletion of the Cul1 gene in mice causes arrest in early embryogenesis and accumulation of cyclin E